Ulcerative Colitis Market is expected to portray promising scenarios, as it is estimated to reach $10.8 billion in 2030 which was initially valued at around $6.3 billion in 2021, thereby registering a CAGR of nearly 5.7% from 2022 to 2030. During the COVID-19 epidemic, the Ulcerative Colitis Market has played a critical role. To deal with the worldwide issue, traditional competitors teamed up...